• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

treatment-resistant breast cancer

Research

Studies identify potential new targets for breast cancer

To boost treatment response in breast cancer, Italian researchers focused on microRNAs, while a UCSF team suggested inhibiting a transcription factor.
Angus Liu Apr 2, 2021 10:00am

Insights into breast tumor heterogeneity could inspire new drugs

Oct 30, 2020 10:05am

Boston Pharma's combo for resistant breast cancer enters phase 1

Oct 7, 2019 8:52am

CRISPR slows the growth of triple-negative breast cancer in mice

Aug 26, 2019 3:00pm

ASCO: Poliovirus combo shrinks breast tumors in mice

Jun 4, 2018 9:21am

New discoveries in cancer and infectious disease—News of Note

Oct 23, 2017 11:00am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy